Screener
Krystal Biotech, Inc. KRYS EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
FAQ
- What is Krystal Biotech, Inc.'s EV / EBITDA?
- Krystal Biotech, Inc. (KRYS) reported EV / EBITDA of 38.3× in Q1 2026.
- How has Krystal Biotech, Inc.'s EV / EBITDA changed year-over-year?
- Krystal Biotech, Inc.'s EV / EBITDA decreased by 10.4% year-over-year, from 42.7× to 38.3×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.
Ask your AI about Krystal Biotech, Inc.'s ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude